Literature DB >> 30457067

Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state.

Leanne Hodson1.   

Abstract

When we consume dietary fat, a series of complex metabolic processes ensures that fatty acids are absorbed, transported around the body and used/stored appropriately. The liver is a central metabolic organ within the human body and has a major role in regulating fat and carbohydrate metabolism. Studying hepatic metabolism in human subjects is challenging; the use of stable isotope tracers and measurement of particles or molecules secreted by the liver such as VLDL-TAG and 3-hydroxybutyrate offers the best insight into postprandial hepatic fatty acid metabolism in human subjects. Diet derived fatty acids are taken up by the liver and mix with fatty acids coming from the lipolysis of adipose tissue, and those already present in the liver (cytosolic TAG) and fatty acids synthesised de novo within the liver from non-lipid precursors (known as de novo lipogenesis). Fatty acids are removed from the liver by secretion as VLDL-TAG and oxidation. Perturbations in these processes have the potential to impact on metabolic health. Whether fatty acids are partitioned towards oxidation or esterification pathways appears to be dependent on a number of metabolic factors; not least ambient insulin concentrations. Moreover, along with the phenotype and lifestyle factors (e.g. habitual diet) of an individual, it is becoming apparent that the composition of the diet (macronutrient and fatty acid composition) may play pivotal roles in determining if intra-hepatic fat accumulates, although what remains to be elucidated is the influence these nutrients have on intra-hepatic fatty acid synthesis and partitioning.

Entities:  

Keywords:  3-OHB 3-hydroxybutyrate; DNL de novo lipogenesis; NAFLD non-alcoholic fatty liver disease; TE total energy; Fatty acid oxidation; Fatty acid partitioning; Liver; VLDL-TAG

Mesh:

Substances:

Year:  2018        PMID: 30457067     DOI: 10.1017/S0029665118002653

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  7 in total

Review 1.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

2.  Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids.

Authors:  Panu K Luukkonen; Auli Nick; Maarit Hölttä-Vuori; Christoph Thiele; Elina Isokuortti; Susanna Lallukka-Brück; You Zhou; Antti Hakkarainen; Nina Lundbom; Markku Peltonen; Marju Orho-Melander; Matej Orešič; Tuulia Hyötyläinen; Leanne Hodson; Elina Ikonen; Hannele Yki-Järvinen
Journal:  JCI Insight       Date:  2019-08-22

3.  Prospective dietary polyunsaturated fatty acid intake is associated with trajectories of fatty liver disease: an 8 year follow-up study from adolescence to young adulthood.

Authors:  Fuzhen Wan; Feng Pan; Oyekoya Ayonrinde; Leon A Adams; Trevor A Mori; Lawrence J Beilin; Therese A O'Sullivan; John K Olynyk; Wendy H Oddy
Journal:  Eur J Nutr       Date:  2022-07-03       Impact factor: 5.614

4.  Food preservative sorbic acid deregulates hepatic fatty acid metabolism.

Authors:  Chia-Hui Chen; Sin-Ni Ho; Po-An Hu; Yu Ru Kou; Tzong-Shyuan Lee
Journal:  J Food Drug Anal       Date:  2020-06-15       Impact factor: 6.157

5.  Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease.

Authors:  Thomas J Velenosi; Gil Ben-Yakov; Maren C Podszun; Julian Hercun; Ohad Etzion; Shanna Yang; Cathy Nadal; Vanessa Haynes-Williams; Wen-Chun A Huang; Lila González-Hódar; Robert J Brychta; Shogo Takahashi; Vikas Akkaraju; Kristopher W Krausz; Mary Walter; Hongyi Cai; Peter J Walter; Ranganath Muniyappa; Kong Y Chen; Frank J Gonzalez; Yaron Rotman
Journal:  Gastroenterology       Date:  2022-03-10       Impact factor: 33.883

6.  AAA-ATPase valosin-containing protein binds the transcription factor SREBP1 and promotes its proteolytic activation by rhomboid protease RHBDL4.

Authors:  Koji Shibuya; Ken Ebihara; Chihiro Ebihara; Nagisa Sawayama; Masayo Isoda; Daisuke Yamamuro; Manabu Takahashi; Shuichi Nagashima; Shun Ishibashi
Journal:  J Biol Chem       Date:  2022-04-14       Impact factor: 5.486

7.  Tuftelin 1 Facilitates Hepatocellular Carcinoma Progression through Regulation of Lipogenesis and Focal Adhesion Maturation.

Authors:  Lei Zhu; Kai X Zhou; Ming Z Ma; Lin L Yao; Yan L Zhang; Hui Li; Chang Du; Xiao M Yang
Journal:  J Immunol Res       Date:  2022-06-19       Impact factor: 4.493

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.